Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMD

BACKGROUND: Although anti-VEGF therapy of exudative AMD with bevacizumab and ranibizumab proved efficacious in the majority of patients, CNV activity does not respond to continued treatment after repeated injections in a considerable amount of patients. These are referred to as nonresponders. A chan...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Ehlken, C, Jungmann, S, Böhringer, D, Agostini, H T, Junker, B, Pielen, A
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group 2014
Pynciau:
Clinical Study
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4017123/
https://ncbi.nlm.nih.gov/pubmed/24722504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2014.64
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg